Carcinogenesis Advance Access originally published online on May 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 8, 1291-1300,
August 2003
© 2003 Oxford University Press
REVIEW |
Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase
1 Laboratory of Chang-Jiang Scholar Endowment for Biomedical Sciences, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, Peoples Republic of China
2 Department of Medicine, University of Colorado School of Medicine, CU Cancer Center, and Denver Health Medical Center, Denver, CO 80204, USA
3 To whom correspondence should be addressed Email: ming-hai.wang{at}uchsc.edu
The product of the RON (recepteur d'origine nantais) gene belongs to the MET proto-oncogene family, a distinct subfamily of receptor tyrosine kinases. The ligand of RON was identified as macrophage-stimulating protein (MSP), a member of the plasminogen-related growth factor family. RON is mainly expressed in cells of epithelial origin and is required for embryonic development. In vitro RON activation results in epithelial cell dissociation, migration and matrix invasion, suggesting that RON might be involved in the pathogenesis of certain epithelial cancers in vivo. Indeed, recent studies have shown that RON expression is significantly altered in several primary human cancers, including those of the breast and colon. Truncation of the RON protein has also been found in primary tumors from the gastrointestinal tract. These alterations lead to constitutive activation of RON that causes cell transformation in vitro, induces neoplasm formation in athymic nude mice, and promotes tumor metastasis into the lung. Studies employing transgenic models further demonstrated that over-expression of RON in lung epithelial cells results in multiple tumor formation with features of large cell undifferentiated carcinoma. The oncogenic activities of RON are mediated by RON-transduced signals that promote unbalanced cell growth and transformation leading to tumor development. Thus, abnormal accumulation and activation of RON could play a critical role in vivo in the progression of certain malignant human epithelial cancers.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Dominguez, B. Gadea, F. J. Esteban, J. A. Horcajadas, A. Pellicer, and C. Simon Comparative protein-profile analysis of implanted versus non-implanted human blastocysts Hum. Reprod., September 1, 2008; 23(9): 1993 - 2000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, P. J. Kaplan-Lefko, K. Rex, Y. Yang, J. Moriguchi, T. Osgood, B. Mattson, A. Coxon, M. Reese, T.-S. Kim, et al. Identification of a Novel Recepteur d'Origine Nantais/c-Met Small-Molecule Kinase Inhibitor with Antitumor Activity In vivo Cancer Res., August 15, 2008; 68(16): 6680 - 6687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Narasimhan and S. Ammanamanchi Curcumin Blocks RON Tyrosine Kinase-Mediated Invasion of Breast Carcinoma Cells Cancer Res., July 1, 2008; 68(13): 5185 - 5192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zhang, H.-P. Yao, and M.-H. Wang Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility Carcinogenesis, March 1, 2008; 29(3): 552 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Welm, J. B. Sneddon, C. Taylor, D. S. A. Nuyten, M. J. van de Vijver, B. H. Hasegawa, and J. M. Bishop The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans PNAS, May 1, 2007; 104(18): 7570 - 7575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. O'Toole, K. E. Rabenau, K. Burns, D. Lu, V. Mangalampalli, P. Balderes, N. Covino, R. Bassi, M. Prewett, K. J. Gottfredsen, et al. Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member. Cancer Res., September 15, 2006; 66(18): 9162 - 9170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Germano, D. Barberis, M. M. Santoro, L. Penengo, A. Citri, Y. Yarden, and G. Gaudino Geldanamycins Trigger a Novel Ron Degradative Pathway, Hampering Oncogenic Signaling J. Biol. Chem., August 4, 2006; 281(31): 21710 - 21719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wei, L. Hao, S. Ni, Q. Liu, J. Xu, and P. H. Correll Altered Exon Usage in the Juxtamembrane Domain of Mouse and Human RON Regulates Receptor Activity and Signaling Specificity J. Biol. Chem., December 2, 2005; 280(48): 40241 - 40251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-M. Xu, Y.-Q. Zhou, and M.-H. Wang Mechanisms of Cytoplasmic {beta}-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase J. Biol. Chem., July 1, 2005; 280(26): 25087 - 25094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matsuzaki, M. Canis, J.L. Pouly, P. Dechelotte, K. Okamura, and G. Mage The macrophage stimulating protein/RON system: a potential novel target for prevention and treatment of endometriosis Mol. Hum. Reprod., May 1, 2005; 11(5): 345 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Camp, W. Liu, F. Fan, A. Yang, R. Somcio, and L. M. Ellis RON, a Tyrosine Kinase Receptor Involved in Tumor Progression and Metastasis Ann. Surg. Oncol., April 1, 2005; 12(4): 273 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yokoyama, I. Ischenko, M. J. Hayman, and W. T. Miller The C Terminus of RON Tyrosine Kinase Plays an Autoinhibitory Role J. Biol. Chem., March 11, 2005; 280(10): 8893 - 8900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hintermann, N. Yang, D. O'Sullivan, J. M. G. Higgins, and V. Quaranta Integrin {alpha}6{beta}4-erbB2 Complex Inhibits Haptotaxis by Up-regulating E-cadherin Cell-Cell Junctions in Keratinocytes J. Biol. Chem., March 4, 2005; 280(9): 8004 - 8015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bardella, B. Costa, P. Maggiora, S. Patane', M. Olivero, G. N. Ranzani, M. De Bortoli, P. M. Comoglio, and M. F. Di Renzo Truncated RON Tyrosine Kinase Drives Tumor Cell Progression and Abrogates Cell-Cell Adhesion Through E-Cadherin Transcriptional Repression Cancer Res., August 1, 2004; 64(15): 5154 - 5161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Angeloni, A. Danilkovitch-Miagkova, A. Miagkov, E. J. Leonard, and M. I. Lerman The Soluble Sema Domain of the RON Receptor Inhibits Macrophage-stimulating Protein-induced Receptor Activation J. Biol. Chem., January 30, 2004; 279(5): 3726 - 3732. [Abstract] [Full Text] [PDF]
|
|